Joe Manchin Is Throwing Joe Biden a Surprise Party
Goody bags include the biggest surprise of all: action on climate change.
Biden Savors Much-Needed Victories. But Will the Highs Overshadow the Lows?
With the midterm elections around the corner, the challenge for President Biden is to make sure his latest successes resonate with Americans who remain deeply skeptical about the future.
Allergan Reaches Tentative $2.37 Billion Deal to Settle Opioid Suits
If finalized, the agreement, along with a companion deal reached by Teva earlier this week, would send as much as $6.6 billion to communities harmed by the opioid epidemic.
Biden Administration Plans to Offer Updated Booster Shots in September
With reformulated shots from Pfizer and Moderna on the horizon, the F.D.A. has decided that Americans under 50 should wait to receive second boosters.
Democrats’ Plan to Fight Inflation May Lower Costs Over Time
A package of tax increases, lower drug prices and other provisions aimed at reducing the federal budget deficit could alleviate rapid price gains.
Manchin, in a Reversal, Agrees to Climate and Tax Package
The West Virginia Democrat, a holdout on his party’s domestic agenda, said the package would reduce inflation, a concern he had cited in rejecting it just weeks ago.
Cómo vivir con la COVID-19 cuando estás harto de la pandemia
El aumento de la subvariante BA.5 es un recordatorio de que debemos tomar precauciones para evitar enfermarnos, desacelerar el ciclo implacable de nuevas variantes y minimizar la interrupción de nuestra vida diaria.
Teva Reaches Tentative $4.25 Billion Settlement Over Opioids
The deal would end thousands of lawsuits against one of the largest producers of opioid painkillers during the height of the opioid epidemic.
Fentanyl From the Government? A Vancouver Experiment Aims to Stop Overdoses
A city on the forefront of harm reduction has taken the concept to a new level in an effort to address the growing toxicity of street drugs.
Omicron BA.5 Surge: 5 Ways to Stay Safe
The BA.5 surge is a reminder that we need to take precautions to avoid illness, slow the relentless cycle of new variants and minimize the disruption to our daily lives.
Call for more information
888-531-0245
info@siii-clinical.com
From research laboratories to clinical settings, SIII integrates the technologies, resources, and expertise our customers need to rise to the next opportunity. SIII is dedicated to exploring and researching the processes and scientific mechanisms underlying the world we live in.